Skip to content

The effectiveness and cost-effectiveness of treatment by homeopaths in addition to usual care for depressed patients

A pragmatic cohort randomized controlled trial of the clinical and cost effectiveness of treatment of depression by homeopaths in addition to usual care, compared to usual care alone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN02484593
Enrollment
485
Registered
2013-01-07
Start date
2013-07-01
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Self-reported depression Mental and Behavioural Disorders Depressive episode, unspecified

Interventions

Individualised treatment provided by homeopaths in addition to usual care, compared to usual care alone.

Sponsors

University of Sheffield (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with self-reported depression indicated by a minimum PHQ-9 score of 10 with a minimum of two symptoms scoring 2 points including at least either question 1 (little interest or pleasure in doing things) or question 2 (feeling down, depressed, or hopeless) 2. Aged 18 to 85 years 3. Are able to speak and read English 4. Have given informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with PHQ-9 scores below 10 or less than 2 symptoms scoring 2 points or neither question 1 nor question 2 scoring 2 points 2. Patients who report current or past psychiatric diagnosis (other than depression) including bipolar disorder, Alzheimer's disease, organic brain damage, schizophrenia, schizoaffective disorders, other psychotic disorders, or antisocial personality disorder 3. Patients who have received homeopathic treatment over the past 3 months 4. Patients who are currently involved in another health research project 5. Patients who due to reduced intellectual capacity or illiteracy are unable to read or understand study questionnaires and accompanying information

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire (PHQ-9) at 6 months

Secondary

MeasureTime frame
1. Patient Health Questionnaire (PHQ-9) at 12 months, and the following at 6 and 12 months 2. Generalized Anxiety Disorder 7-item (GAD-7) scale at 6 and 12 months 3. EuroQol (EQ-5D) at 6 and 12 months 4. Measure Yourself Medical Outcome Profile (MYMOP2) at 6 and 12 months 5. Body Mass Index (BMI) at 6 and 12 months 6. Life satisfaction score at 6 and 12 months

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 9, 2026